Search Medical Condition
Please enter condition
Please choose location from dropdown

Bradenton, Florida Clinical Trials

A listing of Bradenton, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (226) clinical trials

PRC-063 Adult Laboratory Classroom Study in Adults With ADHD

This is a randomized, double-blind, parallel group, placebo-controlled, dose optimized, phase 3 study to evaluate the safety and efficacy of PRC-063 in the treatment of ADHD in adults

Phase

0.0 miles

Learn More »

Evaluation of SPN-812 ER High Dose in Adolescents With ADHD

This is a multicenter, randomized, double-blind, placebo-controlled, 3-arm, parallel-group study, to assess the efficacy and safety of SPN-812 ER as monotherapy for the treatment of children 12-17 years old with ADHD.

Phase

0.0 miles

Learn More »

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

The purpose of the AR19.004 study is to assess the efficacy of AR19 compared to placebo using the Adult ADHD Investigator Symptom Rating Scale (AISRS)

Phase

0.0 miles

Learn More »

A research study of ADHD for adults 18 to 60 years of age that takes place in a classroom setting.  

Phase N/A

0.0 miles

Learn More »

Gan & Lee Insulin Glargine Target Type (2) Evaluating Research

Primary Objective: To demonstrate equivalence of Gan & Lee Insulin Glargine Injection and Lantus in terms of immunogenicity Secondary Objective: Immunogenicity: To evaluate the percentage of subjects with negative anti-insulin antibodies (AIA) at baseline who develop confirmed positive AIA up to Week 26

Phase

0.0 miles

Learn More »

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

Primary Objective: To demonstrate equivalence of Gan & Lee Insulin Glargine Injection and Lantus in terms of immunogenicity Secondary Objective: Immunogenicity: To evaluate the percentage of subjects with negative anti-insulin antibodies (AIA) at baseline who develop confirmed positive AIA up to Week 26

Phase

0.0 miles

Learn More »

Medical management of T2DM involves diet, exercise, weight management, and pharmacotherapy. Pharmacological agents, such as metformin, α-glucosidase inhibitors, orlistat, and thiazolidinediones, have been shown to decrease incident diabetes. Metformin has the strongest evidence base and demonstrated long-term safety as pharmacological therapy for diabetes treatment. The American Diabetes association position statement ...

Phase N/A

0.39 miles

Learn More »

The study compares 2 medicines for type 2 diabetes: fast-acting insulin aspart (a new medicine) and NovoRapid®/NovoLog® (a medicine doctors can already prescribe). Fast-acting insulin aspart will be tested to see how well it works and if it is safe. Participants will get either fast-acting insulin aspart or NovoRapid®/ NovoLog® ...

Phase N/A

0.39 miles

Learn More »

To demonstrate the superiority of sotagliflozin dose 1 versus placebo on hemoglobin A1c (HbA1c) reduction in patients with type 2 diabetes (T2D) who have inadequate glycemic control on diet and exercise.

Phase N/A

0.39 miles

Learn More »

This is a randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study in children with ADHD in a laboratory classroom setting. The study will be comprised of 3 periods: Screening (up to 35 days) including a 3 - 5 day ADHD medication washout prior to Day -1; Double-blind randomized treatment with either ...

Phase N/A

0.39 miles

Learn More »